# The Effect of Dihydroartemisinin in PCOS

> **NCT05465135** · PHASE4 · COMPLETED · sponsor: **Shanghai Zhongshan Hospital** · enrollment: 19 (actual)

## Conditions studied

- Polycystic Ovary Syndrome

## Interventions

- **DRUG:** Dihydroartemisinin

## Key facts

- **NCT ID:** NCT05465135
- **Lead sponsor:** Shanghai Zhongshan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-07-01
- **Primary completion:** 2023-03-23
- **Final completion:** 2023-04-23
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2024-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05465135

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05465135, "The Effect of Dihydroartemisinin in PCOS". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT05465135. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*